Inflation reaching multi-decade highs, uncertainty in the banking world and credit markets drying up dampened private equity health care M&A activity in 2022, especially in the second half. Many anticipate that investment slowdown to continue into 2023, but there’s a good chance the home health industry will buck that trend. Multiple PE firms, such as […]
Establishing a home infusion brand and quickly growing it to become one of the top five providers in the U.S., selling it to a major long-term care pharmacy, and then transitioning into the home health industry might seem like a pipe dream for some. For industry veteran Jim Glynn, however, this dream has become a […]
By continuing to use the site, you agree to the use of cookies. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. For more information, see our cookie policy
